JPS5231054A - Process for manufacture of intermediates of prostaglandin homologs - Google Patents

Process for manufacture of intermediates of prostaglandin homologs

Info

Publication number
JPS5231054A
JPS5231054A JP51107651A JP10765176A JPS5231054A JP S5231054 A JPS5231054 A JP S5231054A JP 51107651 A JP51107651 A JP 51107651A JP 10765176 A JP10765176 A JP 10765176A JP S5231054 A JPS5231054 A JP S5231054A
Authority
JP
Japan
Prior art keywords
prostaglandin
homologs
intermediates
manufacture
prostaglandin homologs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP51107651A
Other languages
Japanese (ja)
Other versions
JPS5728706B2 (en
Inventor
Rosu Jiyonson Maikeru
Yurugen Erunsuto Hesu Hansu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/355,644 external-priority patent/US4094899A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS5231054A publication Critical patent/JPS5231054A/en
Publication of JPS5728706B2 publication Critical patent/JPS5728706B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP51107651A 1972-06-02 1976-09-08 Process for manufacture of intermediates of prostaglandin homologs Granted JPS5231054A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25921572A 1972-06-02 1972-06-02
US05/355,644 US4094899A (en) 1972-06-02 1973-04-30 Oxaprostaglandins

Publications (2)

Publication Number Publication Date
JPS5231054A true JPS5231054A (en) 1977-03-09
JPS5728706B2 JPS5728706B2 (en) 1982-06-18

Family

ID=26947161

Family Applications (3)

Application Number Title Priority Date Filing Date
JP6244973A Expired JPS5314062B2 (en) 1972-06-02 1973-06-02
JP51107650A Pending JPS5239629A (en) 1972-06-02 1976-09-08 Process for manufacturing intermediate of prostaglandins homologs
JP51107651A Granted JPS5231054A (en) 1972-06-02 1976-09-08 Process for manufacture of intermediates of prostaglandin homologs

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP6244973A Expired JPS5314062B2 (en) 1972-06-02 1973-06-02
JP51107650A Pending JPS5239629A (en) 1972-06-02 1976-09-08 Process for manufacturing intermediate of prostaglandins homologs

Country Status (19)

Country Link
JP (3) JPS5314062B2 (en)
AR (2) AR199300A1 (en)
CA (1) CA1095034A (en)
CH (3) CH590224A5 (en)
DD (2) DD109859A5 (en)
DE (2) DE2344838C3 (en)
DK (1) DK143498C (en)
ES (2) ES441003A1 (en)
FI (1) FI55995C (en)
GB (3) GB1440603A (en)
IE (1) IE38568B1 (en)
IL (2) IL42373A (en)
IN (1) IN138739B (en)
LU (1) LU67738A1 (en)
NL (1) NL162902C (en)
NO (1) NO145438C (en)
PH (3) PH11300A (en)
SE (4) SE415756B (en)
YU (1) YU36497B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11756356B2 (en) 2019-08-28 2023-09-12 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES416865A1 (en) * 1972-07-13 1976-03-01 Pfizer 15-substituted-omega-pentanorprostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
ZA721159B (en) * 1971-03-22 1972-12-27 Ici Ltd Process for the separation of the c-15 epimers of 20-ethyl-9a,11alpha,15-trihydroxy-5-cis-13-trans-prostadienoic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11756356B2 (en) 2019-08-28 2023-09-12 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Also Published As

Publication number Publication date
IL50311A (en) 1977-08-31
CH589074A5 (en) 1977-06-30
SE7608221L (en) 1976-07-19
NO740849L (en) 1973-12-04
IE38568L (en) 1973-12-02
DD124594A5 (en) 1977-03-02
FI55995B (en) 1979-07-31
GB1440603A (en) 1976-06-23
JPS5314062B2 (en) 1978-05-15
IL42373A (en) 1977-08-31
SE7608223L (en) 1976-07-19
SE415756B (en) 1980-10-27
PH11300A (en) 1977-11-02
DE2344838B2 (en) 1981-04-09
CH590224A5 (en) 1977-07-29
AU5639373A (en) 1974-12-05
SE7608222L (en) 1976-07-19
ES441002A1 (en) 1977-03-01
CH586716A5 (en) 1977-04-15
NO145438B (en) 1981-12-14
DE2344838A1 (en) 1973-12-20
ES441003A1 (en) 1977-03-16
DE2327813A1 (en) 1973-12-20
JPS4954349A (en) 1974-05-27
NL162902C (en) 1980-07-15
YU36497B (en) 1984-02-29
JPS5728706B2 (en) 1982-06-18
DK143498B (en) 1981-08-31
DK143498C (en) 1982-01-11
NL7307740A (en) 1973-12-04
NO145438C (en) 1982-03-24
IE38568B1 (en) 1978-04-12
DD109859A5 (en) 1974-11-20
DE2344839B2 (en) 1976-06-24
GB1440602A (en) 1976-06-23
CA1095034A (en) 1981-02-03
GB1440601A (en) 1976-06-23
YU146973A (en) 1982-02-25
LU67738A1 (en) 1973-12-10
NL162902B (en) 1980-02-15
DE2344839A1 (en) 1974-02-28
SE418857B (en) 1981-06-29
AR203386A1 (en) 1975-09-08
PH12035A (en) 1978-10-16
IN138739B (en) 1976-03-27
DE2344838C3 (en) 1982-03-18
FI55995C (en) 1979-11-12
IL42373A0 (en) 1973-07-30
JPS5239629A (en) 1977-03-28
AR199300A1 (en) 1974-08-23
PH11931A (en) 1978-09-13

Similar Documents

Publication Publication Date Title
JPS52142045A (en) Process for manufacture of cyclopropane derivatives
JPS5253841A (en) Process for manufacture of intermediates of substituted omegaapentanolprostaglandins
MY7600089A (en) Process for the production of dinethyl ether
CH540929A (en) Process for the production of 5-iodo-deoxy-uridine
KR780000002B1 (en) Process for the production of saccarase inhibitor
CS180047B2 (en) Method for production of novel prostaglandins
JPS5231054A (en) Process for manufacture of intermediates of prostaglandin homologs
YU121973A (en) Process for obtaining silylesters of azetidine-2-sulfenate
ZA743557B (en) Process for prostaglandin intermediates
JPS5781457A (en) Manufacture of prostaglandin like compound
GB1403502A (en) Prostaglandin intermediates
YU299579A (en) Process for obtaining novel derivatives of aminoimidazoloisoquinoline
YU287973A (en) Process for obtaining new p-biphenyl esters of 15-substituted omega-pentano prostaglandins
KR780000001B1 (en) Process for the production of saccarase inhibitor
CS179917B2 (en) Method for production of novel aminopropanols
MC969A1 (en) New process for the preparation of 2-methoxy-5-alkylsulfonylbenzamides
CS188194B2 (en) Method of producing novel intermediates for 15-substituted omega-penta-nor-prostaglandins
CH539010A (en) Process for the continuous production of B-methoxy-aldehydes
BE778280A (en) PROCESS FOR THE PRODUCTION OF NITRILOTRIACETONITRILE (
HU172029B (en) Process for preparing cyclopentane-aldehyde derivatives applicable as prostaglandin intermediates
PH14022A (en) Process of resolution for prostaglandine intermediates
CA963467A (en) Process for the production of triazolobenzodiazepine intermediates
CA890445A (en) Preparation of prostaglandin intermediates
CA900499A (en) Process of producing fluorane compound
CA904890A (en) Process for the production of primary alkenols